SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-003487
Filing Date
2022-01-27
Accepted
2022-01-27 18:41:13
Documents
1
Period of Report
2022-01-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4169
  Complete submission text file 0000899243-22-003487.txt   5579
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Issuer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O CALITHERA BIOSCIENCES, INC. 343 OYSTER POINT BLVD., SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Molineaux Susan (Reporting) CIK: 0001553389 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36644 | Film No.: 22564748